Brought to you by 
AHP, Elan develop Alzheimer's vaccine; concluded
Aug 2000
Executive Summary
American Home Products and Elan will research, develop, and potentially sell a vaccine to treat and possibly prevent the onset of Alzheimer's disease. Terms call for AHP to pay Elan an up-front fee and development and regulatory milestones.
Deal Industry
- Biotechnology
-
Pharmaceuticals
- Vaccines
Deal Status
- Concluded
Deal Type
-
Alliance
- Includes Royalty or Profit Split Information
- R+D and Marketing-Licensing
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
AHP, Elan develop Alzheimer's vaccine; concluded
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice